Long Non-coding RNA DUXAP8 Regulates the Cell Proliferation and Invasion of Non-small-cell Lung Cancer

Overview

Journal Open Life Sci

Specialty Biology

Date 2021 Apr 5

PMID 33817152

Citations 4

Authors

Si-Jia Yang

Jia-Lu Weng

Bin Wei

Xue-Kui Du

Affiliations

Soon will be listed here.

Abstract

To investigate how long non-coding RNAs DUXAP8 (LncRNA DUXAP8) influence the cell proliferation and invasion of non-small-cell lung cancer (NSCLC), we detected the expression levels of LncRNA DUXAP8 in lung cancer (LC) tissues, 4 LC-related cell lines (A549, SPC-A1, SK-MES-1 and NCI-H1299) and normal lung tissues via quantitative real-time PCR (qRT-PCR). Compared with normal lung tissue, LncRNA DUXAP8 was significantly up-regulated in NSCLC, especially in stage III / IV and diameter ≥ 3cm of lung cancer. Among 4 lung cancer cell lines, LncRNA DUXAP8 in A549 cells was the highest (<0.001). Construction of LncRNA DUXAP8 overexpression and LncRNA DUXAP8 knockout in A549 cell lines was further performed and subsequently injected into nude mice to build an in vivo tumor xenograft model. The results indicated that LncRNA DUXAP8 overexpression significantly promoted the A549 cells' proliferation, enhanced invasion and induced tumor growth. Conversely, LncRNA DUXAP8 knockout significantly suppressed A549 cells' proliferation, weakened invasion and inhibited tumor growth. Taken together, our results imply that LncRNA DUXAP8 is a potential regulatory molecular marker in non-small-cell lung cancer.

Citing Articles

Pseudogenes in Cancer: State of the Art.

Nakamura-Garcia A, Espinal-Enriquez J Cancers (Basel). 2023; 15(16).

PMID: 37627052 PMC: 10452131. DOI: 10.3390/cancers15164024.

LncRNA as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.

Wang Y, Jiang X, Zhang D, Zhao Y, Han X, Zhu L Front Genet. 2022; 13:907774.

PMID: 36046244 PMC: 9420988. DOI: 10.3389/fgene.2022.907774.

Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Wu C, Song W, Wang Z, Wang B Mol Biol Rep. 2022; 49(3):2531-2542.

PMID: 35031926 DOI: 10.1007/s11033-021-07066-6.

Long Non-coding RNA Double Homeobox A Pseudogene 8: A Novel Oncogenic Propellant in Human Cancer.

Xue C, Cai X, Jia J Front Cell Dev Biol. 2021; 9:709069.

PMID: 34631702 PMC: 8495153. DOI: 10.3389/fcell.2021.709069.

References

Ma H, Xie M, Sun M, Chen T, Jin R, Ma T . The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression. Oncotarget. 2017; 8(32):52211-52224. PMC: 5581023. DOI: 10.18632/oncotarget.11075. View

Ma Z, Huang H, Xu Y, He X, Wang J, Hui B . Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors. Onco Targets Ther. 2017; 10:4711-4717. PMC: 5626378. DOI: 10.2147/OTT.S136915. View

Yu P, Kang A, Jing L, Wang Y . Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2018; 22(4):993-1002. DOI: 10.26355/eurrev_201802_14381. View

Zhang L, Shi S, Zhu Y, Qian T, Wang H . Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2018; 22(1):142-149. DOI: 10.26355/eurrev_201801_14111. View

Zhang E, Yin D, Sun M, Kong R, Liu X, You L . P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014; 5:e1243. PMC: 4047917. DOI: 10.1038/cddis.2014.201. View

Lin M, Hong Y, Zhang Y, Lin B, He X . Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN. Eur Rev Med Pharmacol Sci. 2018; 22(11):3370-3377. DOI: 10.26355/eurrev_201806_15158. View

Ettinger D, Akerley W, Bepler G, Blum M, Chang A, Cheney R . Non-small cell lung cancer. J Natl Compr Canc Netw. 2010; 8(7):740-801. DOI: 10.6004/jnccn.2010.0056. View

Kazandjian D, Blumenthal G, Yuan W, He K, Keegan P, Pazdur R . FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2016; 22(6):1307-12. DOI: 10.1158/1078-0432.CCR-15-2266. View

Whang Y, Park S, Trenary I, Egnatchik R, Fessel J, Kaufman J . LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells. Oncogene. 2015; 35(7):856-66. PMC: 4486321. DOI: 10.1038/onc.2015.140. View

10.

Uchibori K, Inase N, Araki M, Kamada M, Sato S, Okuno Y . Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nat Commun. 2017; 8:14768. PMC: 5355811. DOI: 10.1038/ncomms14768. View

11.

Gao H, Wu B, Yan W, Gong Z, Sun Q, Wang H . Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma. Oncol Rep. 2017; 38(3):1363-1372. PMC: 5549037. DOI: 10.3892/or.2017.5821. View

12.

Xu L, Yu X, Wei B, Hui H, Sun Y, Dai J . Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer. Eur Rev Med Pharmacol Sci. 2018; 22(9):2646-2652. DOI: 10.26355/eurrev_201805_14959. View

13.

Osielska M, Jagodzinski P . Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?. Biomed Pharmacother. 2018; 101:322-333. DOI: 10.1016/j.biopha.2018.02.099. View

14.

Zhao B, Hou X, Zhan H . Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells. Int J Clin Exp Med. 2016; 8(10):18482-7. PMC: 4694356. View

15.

Wang L, Hu Y, Xiang X, Qu K, Teng Y . Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer. Oncotarget. 2017; 8(38):64191-64202. PMC: 5609994. DOI: 10.18632/oncotarget.19828. View

16.

Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T . Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011; 71(20):6320-6. DOI: 10.1158/0008-5472.CAN-11-1021. View

17.

Gutschner T, Diederichs S . The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012; 9(6):703-19. PMC: 3495743. DOI: 10.4161/rna.20481. View

18.

Sun M, Nie F, Zang C, Wang Y, Hou J, Wei C . The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB. Mol Ther. 2017; 25(3):739-751. PMC: 5363203. DOI: 10.1016/j.ymthe.2016.12.018. View

19.

Zhang G, An X, Zhao H, Zhang Q, Zhao H . Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer. Biomed Pharmacother. 2018; 98:594-599. DOI: 10.1016/j.biopha.2017.12.080. View

20.

Liu X, Liu Z, Sun M, Liu J, Wang Z, De W . The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013; 13:464. PMC: 3851855. DOI: 10.1186/1471-2407-13-464. View